significant public health implications due to its association with increased incidence of cardiovascular disease 3)-5) that are the most prevalent cause of mortality in Japan. Therefore, it is imperative to identify the individuals with the metabolic syndrome and provide measures to treat the multitude of metabolic abnormalities in the early phase of the syndrome. In 2005, the Examination Committee of Criteria for the Metabolic Syndrome in Japan 6) and International Diabetic Federation 7) proposed new sets of criteria for the diagnosis of the metabolic syndrome. A notable common feature in these criteria is that they both recognize the abdominal fat accumulation evaluated by the waist circumference measured at the level of umbilicus as the essential criterion for the diagnosis of the syndrome. The role for abdominal fat accumulation has been strongly implicated in the development of disorders such as impaired glucose tolerance, hypertension, and dyslipidemia, all of which contribute to the process of atherosclerosis. 8) Waist circumference measurement is a simple and widely applicable method to evaluate central obesity. However, since it is affected by the subcutaneous fat, it does not exactly reflect the abdominal fat accumulation. Currently available methods that reliably measure the abdominal fat accumulation are computed tomography (CT) and magnetic resonance imaging (MRI). 9),10) However, these methods are not available for routine use.
Here, we used CT data obtained in the course of workplace-subsidized general health examination program to evaluate visceral fat accumulation, and analyzed the cross-sectional data acquired in the period between January 2001 and November 2005 for the Metabolic Syndrome and Abdominal Obesity at NTT West Kyoto Study (MONK Study) to investigate the prevalence of the metabolic syndrome in an adult Japanese population. We also analyzed the sensitivity and the specificity of VFA values as a diagnostic criterion of the metabolic syndrome.
Subjects and methods. We reviewed data of 4249 adult subjects, 3551 men and 698 women, at the age of 49.1 ± 7.6 and 49.6 ± 6.4 years (mean ± standard deviation (SD)), respectively, from the employee and their family members of a telecommunication company and its subsidiaries that employed 69,000 people in western Japan, who lived in Kinki area. The subjects included 3535 men and 686 women who underwent a corporatesubsidized general health examination program offered to the employees and their family members, and 16 men and 12 women who underwent a yearly workplace health screenings performed at NTT West Kyoto Hospital. All the subjects voluntarily chose to be examined by CT for the VFA. Subjects who had any of specific treatments for hypertension, hyperlipidemia or diabetes were included in the study. Overall, 437 men and 38 women were taking antihypertensive agents, 45 men and one woman were taking anti-hypertriglyceride agents, and 97 men and 7 women were taking antidiabetic agents. The examinations included a physical check-up, a set of biochemical analyses of blood samples, and a CT evaluation for visceral fat accumulation between 9:00 and 10:00 AM.
The body weight in light clothes was measured to the nearest 0.1 kg and the height to the nearest 0.1 cm. Body mass index (BMI) was calculated as weight (kg) divided by the square of height (m 2 ). Blood pressure (BP) in the morning was measured in either the left or right arm using a mercury sphygmomanometer in the sitting position and recorded in mmHg. Visceral fat accumulation was examined at the umbilical level in the supine position using CT (X Vision Scanner, Toshiba Medical Systems, Tokyo, Japan), as described previously.
11) VFA was determined using a commercial software package (Fat Scan, N2 System, Osaka, Japan). To measure triglyceride (TG), high-density lipoprotein cholesterol (HDLC) and fasting plasma glucose (FPG), blood samples were obtained at 9:00 AM after an overnight fast. TG was measured by an enzymatic method (Daiichi Pure Chemicals, Tokyo). HDLC was measured using the proprietary detergent method (Daiichi Pure Chemicals, Tokyo). FPG was measured by enzymatic methods utilizing glucose oxidase or hexokinase (Wako Pure Chemical Industries, Osaka).
We examined the waist circumference in 164 men and 53 women randomly chosen from the subjects and investigated the relationship between their VFA and waist circumference. The waist circumference was measured to the nearest 0.5 cm at the level of umbilicus in the late exhalation phase in the standing position by a well-trained technician.
The study took place from January 2001 to November 2005. This study was approved by the ethical committee of NTT West Kyoto Hospital.
Diagnosis of the metabolic syndrome. The diagnosis of the metabolic syndrome was made essentially in accordance with the definition by the Examination Committee of Criteria for the Metabolic Syndrome in Japan (Table I) . 6) In place of waist circumference, VFA by CT was used as the measure of visceral fat accumulation. According to the Japanese diagnostic criteria, the waist circumference of 85 cm in men and 90 cm in women are equivalent to the VFA value of 100 cm 2 in both gender. With subjects who were on specific treatments for the components examined in the diagnosis of the syndrome, each treatment was counted as a positive component for the diagonosis. Statistical analysis. Data were expressed as means ± SD or standard error of means (SEM). Correlations were assessed using Spearman's rank cor-
[Vol. 81(B), relation test. To identify the optimal VFA as a predictor of the presence of at least two components comprising the metabolic syndrome other than visceral fat accumulation, we performed receiver operating characteristic (ROC) analysis using the data obtained for the age group 40-59 years. P values of less than 0.05 were considered as significant. The statistical software SPSS for Windows (Version 8.0) and StatView5.0 were used for the analyses.
Results. Table II shows the characteristics of the study population by age group. Of men, 1.2% were aged 20-29 years, 11.9% were 30-39 years, 31.3% were 40-49 years, 51.7% were 50-59 years, and 3.9% were ≥ 60 years. In women, 1.7% were aged 20-29 years, 6.0% were 30-39 years, 36.2% 40-49 years, 53.6% were 50-59 years, and 2.4% were ≥ 60 years. With increasing age, BP, FPG and HbA1c in men, and, BMI, BP, total cholesterol, TG, FPG and HbA1c in women showed gradual increase. The respective values were similar in general to those in the National Health and Nutrition Survey in Japan 12) (NHNSJ) in every age group, which studied the adult population from randomly chosen households. Since 83.0% of men and 89.8% of women of our study subjects were in the age group of 40-59 years, and the prevalence of the metabolic syndrome is known to rise in this age group, we examined this group in the subsequent analyses. Figure 1 shows the histogram of BMI and VFA in men and women aged 40-59 years. In both men and women, BMI exhibited a nearly symmetrical distribution around the mean values of 24.1 ± 2.7 kg/m 2 in men, and 22.8 ± 3.2 kg/m 2 in women. These numbers were nearly the same as those for the corresponding age . Those in women showed a peak at a lower portion of the distribution with a modal value in the range of 20-40 cm 2 , and a median value of 52.6 cm 2 .
According to the criteria described in Table I , the prevalence of visceral fat accumulation (VFA ≥ 100 cm 2 by CT) was 50.5% in men and 11.6% in women. The frequencies of each component comprising the metabolic syndrome were as follows: In men with visceral fat accumulation, raised TG and/or reduced HDLC was 50.4%, raised BP was 67.2% and raised FPG was 35.4%; in women with visceral fat accumulation, raised TG and/or reduced HDLC was 28.8%, raised BP was 69.9% and raised FPG was 43.8%. Based on the current diagnostic criteria (VFA ≥ 100 cm 2 plus at least two of the three components), 6 ) the prevalence of the metabolic syndrome was 25.5% in men and 5.4% in women of the age from 40 to 59 years. Among the subjects with visceral fat accumulation defined as VFA ≥ 100 cm 2 , 50.5% of the male and 46.6% of the female were diagnosed with the metabolic syndrome. Figure 2 shows the relationship between VFA and the average number of the metabolic syndrome components in an individual excluding visceral fat accumulation. In men and women, the average number of the metabolic syndrome components in an individual showed a gradual increase as their VFA increased beyond VFA of 60 cm 2 . Table III shows the numbers and the percentages of the middle aged subjects who were found with the respective number of the metabolic syndrome components, within each subgroup stratified by the VFA. Men with one component of the metabolic syndrome were the most frequent in the groups with VFA from 60 cm 2 up to 120 cm 2 , while those with two components were the most frequent in the groups with VFA above 120 cm 2 .
Men with three components increased in proportion within each VFA group as VFA increased. In women, the , those with one component were the most frequent. The proportion of the female with at least two of the metabolic syndrome components increased as VFA increased, and with VFA ≥ 120 cm 2 , 50% of them had either two or three components.
We performed gender-specific ROC analysis to assess the diagnostic accuracy of VFA as an indicator of the presence of at least two of the three components comprising the metabolic syndrome excluding visceral fat accumulation (Fig. 3) We subsequently reassessed the prevalence rates for the components of the metabolic syndrome in women, using 65 cm 2 of VFA as the cutoff point of visceral fat accumulation. The revised prevalence of visceral fat accumulation was 36.7% in women. The revised prevalence of the components comprising the metabolic syndrome were 21.7% for raised TG and/or reduced HDLC, 58.7% for raised BP, and 30.0% for raised FPG among the female with visceral fat accumulation. As a result, the revised prevalence of the metabolic syndrome was 11.0% of women, and 30.0% of the women with visceral fat accumulation. When younger (40-49 years, average age: 45.2 ± 2.8 in men; 46.5 ± 2.5 in women) and older (50-59 years, average age: 54.1 ± 2.7 in men; 53.3 ± 2.6 in women) subgroups were separately analyzed, the sensitivity and the specificity of the optimal VFA at 105 cm 2 for men were 0.66 and 0.62 in the older group, and those of the optimal VFA at 70 cm 2 for women were 0.71 and 0.71 in this age
[Vol. 81(B), Fig. 3 . Gender-specific ROC of VFA for the diagnosis of the presence of at least two of the metabolic syndrome components (raised TG and/or reduced HDLC, raised BP, and raised FPG). The curves are for men (bold line) and women (broken line) from a large company in Kinki area of Japan examined in 2001-2005. The points corresponding to the VFA value of 100 cm 2 for men (closed circle) and 65 cmgroup, respectively. In the younger group, the sensitivity and the specificity were 0.61 and 0.63 at the optimal VFA of 100 cm 2 for men, and 0.67 and 0.69 at VFA of 55 cm 2 for women. We further determined the prevalence of the metabolic syndrome within each subgroups. In men, the prevalences were 22.4% for the 40-49 years, and 27.4% for the 50-59 years. In women, the prevalences were 6.7% for the younger, and 13.9% for the older group.
As shown in Fig. 4 , there was a strong correlation between their VFA and waist circumference (Fig. 4 , r = 0.58 in men, r = 0.69 in women). Waist circumference that was equivalent to 100 cm 2 of VFA in men was 86.0 cm. The value that was equivalent to 65 cm 2 of VFA in women was 77.0 cm. Discussion. The present study has analyzed the metabolic syndrome in a group of Japanese men and women aged 40-59 years, based on precise assessment of visceral adiposity using CT data, and described their profile in detail. It is notable that the study population in the present study is better defined than previous studies in Japan.
In men, using VFA ≥ 100 cm 2 as defined in the current criteria for Japanese, 6),13) the prevalence of the metabolic syndrome was 25.5% in the age group 40-59 years. Our results showed that the VFA value of 100 cm 2 has optimal sensitivity and specificity for diagnosis of the metabolic syndrome in men. It is notable that the prevalence for men is comparable to the result from a study of the metabolic syndrome in another Japanese population that used waist circumference in the diagnostic criteria. 14) In women, however, the VFA of 100 cm 2 is too large as a diagnostic criterion compared with men. We found VFA ≥ 65 cm 2 for women as the cutoff equivalent to VFA ≥ 100 cm 2 for men in terms of the diagnostic sensitivity and specificity. Using VFA ≥ 65 cm 2 as the criterion, the revised prevalence of the metabolic syndrome in women increased from 5.4% to 11.0%. The ratio of the prevalence of the metabolic syndrome in men to that in women (25.5% vs 11.0%) obtained in the present study is compatible wtih those of the mortality from coronary heart disease (35.7 male vs 17.5 female, per 100,000), and cerebrovascular disease (60.5 male vs 38.4 female, per 100,000) in Japan. 15),16) As shown in Table II, the metabolic and the anthropometric profile of the subjects in the present study was mostly in agreement with the results from the study that is representative of the general population in Japan. 12) Therefore, it is conceivable that our result is a reasonably accurate estimate of the prevalence of the metabolic syndrome in the working middle age population in Japan.
When the age groups of 40-49 years and 50-59 years were compared, the optimal cutoff value of VFA was smaller in the younger group than the older group, both in men and women. This may be because average BMI increases with ageing, 12) and therefore the cutoff point rises in the older group. Alternatively, this may reflect the historical change in the socioeconomic environment in Japan. Japan's gross national product grew from the devastation by World War II to become the sec- If that is the case, it implies that the younger Japanese generation has a higher potential of developing the metabolic syndrome than the older generation, and therefore, the prevalence of the syndrome will increase in Japan as the younger generation advances in age. The difference of optimal cutoff between the younger and the older group was 5 cm 2 for men, and 15 cm 2 for women, even though the VFA value for women were smaller than that for men. Therefore, the difference was much larger for women than the difference found for men. This might be explained in part by menopause in women.
17), 18) In the current definition by IDF, 7) ethnicity-specific waist circumference cutoff values have been employed (Table IV) . The cutoff points for Asians are 90 cm in men, and 80 cm in women, while those for Japanese are 85 cm in men, and 90 cm in women. The waist circumference value for women is higher than that for men under the Japanese criteria, 6) because these cutoff values are derived from the waist circumference that corresponds to 100 cm 2 of VFA for men and women. 13) It was based on the report that the average number of obesityrelated disorders present in a person was greater than one when the VFA was larger than 100 cm 2 , and that the combination of the sensitivity and the specificity for determining subjects with multiple risk factors was optimal at the VFA of 100 cm 2 . However, obesity-related disorders other than the components of the metabolic syndrome were included in the previous study, which might have resulted in the higher cutoff value of VFA for women 13) , 19) than the one obtained in the present study.
In summary, the present study analyzed 3574 subjects aged 40-59 years using CT data to evaluate the visceral fat accumulation accurately, and elucidated the prevalence of the metabolic syndrome in Japanese. The prevalence of the syndrome in men is 25.5%, and that in women is 11.0%. The optimal VFA cutoff for the diagnosis of the metabolic syndrome for men and for women are 100 cm 2 and 65 cm 2 , respectively. The corresponding waist circumferences are 86.0 cm for men and 77.0 cm for women.
The present result suggests that, with regards to the prevalence of the metabolic syndrome and waist circumference or abdominal fat accumulation in Japanese, further studies are necessary that include other age groups and population from different geographic area.
It must be emphasized that, although the extent of obesity in Japan is low when compared with western countries, the metabolic syndrome has a substantial prevalence in Japan. 
